Women Health Diagnostics Market
Global Women Health Diagnostics Market Size, Share & Trends Analysis Report by Application (Breast Cancer Testing, Cervical Cancer Testing, Pregnancy & Fertility Testing, Ovarian Cancer Testing, Infectious Disease Testing, Ultrasound Tests, Sexually Transmitted Disease Testing, and Others), and by End-Users (Diagnostic and Imaging Centers, Hospitals and Clinics, and Home Care) Forecast Period (2022-2028)
The global women health diagnostics market is anticipated to grow at a significant CAGR of 7.9% during the forecast period. Women's major health issues related to the reproductive system include infertility, polycystic ovarian syndrome, menopause, and cancers such as breast cancer, cervical cancer, and urological disorders. According to World Health Organization (WHO), in 2020, there were 2.3 million women diagnosed with breast cancer and 685 000 deaths globally. In addition, there were 7.8 million women who were diagnosed with breast cancer in the past 5 years. The increasing number of cancer patients along with growing awareness regarding the various benefits and facilities provided in hospitals is the major factor that is supporting the growth of the women health diagnostics market.
Impact of COVID-19 Pandemic on Global Women Health Diagnostics Market
During the COVID-19 pandemic, limited transportation options and travel restrictions created hurdles to international trade and transportation, which disrupted the supply chain for the women’s health diagnostics market, temporarily leading to a decline in demand due to uncertainty in the capital market and the global economy. The unfavorable changes in guidelines and regulations are impeding the growth of this sector. Major regulatory authorities have identified that breast cancer patients are at greater risk of COVID-19 infection than healthy adults. Thus, screening, surgical procedures, and diagnostic exams are being postponed and severely restricted at hospitals and breast cancer centers. According to an article in the JAMA Network in August 2020, there was a significant decline in breast cancer diagnoses by 51.8% in the US from March 2020 to April 2020. The delay in breast cancer diagnosis also impacted the treatment of the same, which is expected to disrupt the breast cancer treatment and diagnosis market.
Segmental Outlook
The global women health diagnostics market is segmented based on application and end-users. Based on application, the market is bifurcated into breast cancer testing, cervical cancer testing, pregnancy & fertility testing, ovarian cancer testing, infectious disease testing, ultrasound tests, sexually transmitted disease testing, and others. The other segment comprises osteoporosis testing and prenatal genetic testing. Further, based on the end-users, the market is sub-segmented into diagnostic and imaging centers, hospitals and clinics, and home care.
Global Women health diagnostics Market Share by Application, 2021 (%)
The Breast Cancer Testing Segment is Expected to Hold a Prominent Share in the Global Women Health Diagnostics Market
In women, cancer is the group of diseases that occurred as breast cancer, prostate cancer, lung cancer, and colorectal cancer. Breast cancer is the most common cancer among women, other than skin cancer. One woman in nine will develop breast cancer during their lifetime. It is the second leading cause of cancer deaths in women, after lung cancer. It is the leading cause of cancer death among women aged 40 to 55. Moreover, the introduction of technologically advanced hybrid imaging instruments with enhanced accuracy, are some other factors propelling the market growth. For instance, in December 2021, Quest Diagnostics acquired Labtech Diagnostic catering to broaden access to diagnostic innovation in the Southeast region of North America.
Regional Outlooks
The global women health diagnostics market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. The North American region is anticipated to be the fastest-growing region in the women health diagnostic market owing to the presence of well-developed healthcare infrastructure in the region. The presence of major market players in the countries such as the US and Canada along with the increasing number of cancer patients, and obesity are some of the primary factors to boost the regional growth of the market.
Global Women Health Diagnostics Market Growth, by Region 2022-2028
North America Accounts to Register a Significant Share in the Global Women Health Diagnostics Market
North America contributes a significant share of the global health diagnostics market due to the high development and adoption of technologically advanced products. For instance, in March 2022, Royal Philips launched an Ultrasound workspace at the American College of Cardiology's Annual Scientific Session & Expo. Ultrasound workspace is a vendor-neutral echocardiography image analysis and reporting solution that can be accessed remotely through a browser. Clinicians can leverage seamless diagnostic workflows from the ultrasound exam room to the reporting room and beyond, wherever echocardiography data needs to be reviewed and analyzed.
Market Players Outlook
The major companies serving the global women health diagnostics market include Abbott Laboratories, Inc., Becton, Dickson and Co., Biomerieux SA, DIALAB Gmbh, EKF Diagnostics Holdings PLC General Electric Co., Nova Biomedical Pte. Ltd., and others. The companies are focusing on product innovations, expansions, mergers, and acquisitions, partnerships, collaborations, and finding a new market or innovation in their core competency to expand individual market share. For instance, in November 2021, Siemens Healthineers launched the first CT scanner with photon-counting technology. Cleared for clinical use in the US and Europe, more than 20 systems were installed, over 8.000 patients scanned, and over 500 patents filed related to photon-counting.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global women health diagnostics market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Women Health Diagnostics Market
• Recovery Scenario of Global Women Health Diagnostics Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Abbott Laboratories, Inc.
3.1.1.1. Overview
3.1.1.2. Financial Analysis
3.1.1.3. SWOT Analysis
3.1.1.4. Recent Developments
3.1.2. Becton, Dickinson, and Co.
3.1.2.1. Overview
3.1.2.2. Financial Analysis
3.1.2.3. SWOT Analysis
3.1.2.4. Recent Developments
3.1.3. General Electric Co.
3.1.3.1. Overview
3.1.3.2. Financial Analysis
3.1.3.3. SWOT Analysis
3.1.3.4. Recent Developments
3.1.4. Quest Diagnostics Inc.
Overview
3.1.4.1. Financial Analysis
3.1.4.2. SWOT Analysis
3.1.4.3. Recent Developments
3.1.5. Siemens AG
3.1.5.1. Overview
3.1.5.2. Financial Analysis
3.1.5.3. SWOT Analysis
3.1.5.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Women Health Diagnostics Market by Application
4.1.1. Breast Cancer Testing
4.1.2. Cervical Cancer Testing
4.1.3. Pregnancy & Fertility Testing
4.1.4. Ovarian Cancer Testing
4.1.5. Infectious Disease Testing
4.1.6. Ultrasound Tests
4.1.7. Sexually Transmitted Disease Testing
4.1.8. Others (Osteoporosis Testing and Prenatal Genetic Testing)
4.2. Global Women Health Diagnostics Market by End-Users
4.2.1. Diagnostic and Imaging Centers
4.2.2. Hospitals and Clinics
4.2.3. Home Care
5. Regional Analysis
5.1. North America
5.1.1. US
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Biomerieux SA
6.2. DIALAB GmbH
6.3. EKF Diagnostics Holdings PLC
6.4. F. Hoffmann-La Roche Ltd.
6.5. Fujifilm Holdings Corp.
6.6. GenMark Diagnostics, Inc.
6.7. Hologic, Inc.
6.8. Koninklijke Philips N.V.
6.9. Luminex Corp.
6.10. Nova Biomedical Pte. Ltd.
6.11. PerkinElmer Inc.
6.12. QIAGEN N.V.
6.13. Somagen Diagnostics Inc.
6.14. Thermo Fisher Scientific Inc.
6.15. Trinity Biotech PLC
1. GLOBAL WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
2. GLOBAL WOMEN HEALTH DIAGNOSTICS FOR BREAST CANCER TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL WOMEN HEALTH DIAGNOSTICS FOR CERVICAL CANCER TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL WOMEN HEALTH DIAGNOSTICS FOR PREGNANCY & FERTILITY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL WOMEN HEALTH DIAGNOSTICS FOR OVARIAN CANCER TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL WOMEN HEALTH DIAGNOSTICS FOR INFECTIOUS DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL WOMEN HEALTH DIAGNOSTICS FOR ULTRASOUND TESTS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL WOMEN HEALTH DIAGNOSTICS FOR SEXUALLY TRANSMITTED DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL WOMEN HEALTH DIAGNOSTICS FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2021-2028 ($ MILLION)
11. GLOBAL WOMEN HEALTH DIAGNOSTICS IN DIAGNOSTIC AND IMAGING CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL WOMEN HEALTH DIAGNOSTICS IN HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL WOMEN HEALTH DIAGNOSTICS IN HOME CARE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. GLOBAL WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
15. NORTH AMERICAN WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
16. NORTH AMERICAN WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
17. NORTH AMERICAN WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2021-2028 ($ MILLION)
18. EUROPEAN WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
19. EUROPEAN WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
20. EUROPEAN WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2021-2028 ($ MILLION)
21. ASIA-PACIFIC WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
22. ASIA-PACIFIC WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
23. ASIA-PACIFIC WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2021-2028 ($ MILLION)
24. REST OF THE WORLD WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
25. REST OF THE WORLD WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL WOMEN HEALTH DIAGNOSTICS MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL WOMEN HEALTH DIAGNOSTICS MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL WOMEN HEALTH DIAGNOSTICS MARKET, 2022-2028 (%)
4. GLOBAL WOMEN HEALTH DIAGNOSTICS MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
5. GLOBAL WOMEN HEALTH DIAGNOSTICS FOR BREAST CANCER TESTING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL WOMEN HEALTH DIAGNOSTICS FOR CERVICAL CANCER TESTING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL WOMEN HEALTH DIAGNOSTICS FOR PREGNANCY & FERTILITY TESTING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL WOMEN HEALTH DIAGNOSTICS FOR OVARIAN CANCER TESTING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL WOMEN HEALTH DIAGNOSTICS FOR INFECTIOUS DISEASE TESTING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL WOMEN HEALTH DIAGNOSTICS FOR ULTRASOUND TESTS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL WOMEN HEALTH DIAGNOSTICS FOR SEXUALLY TRANSMITTED DISEASE TESTING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL WOMEN HEALTH DIAGNOSTICS FOR OTHERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL WOMEN HEALTH DIAGNOSTICS MARKET SHARE BY END-USERS, 2021 VS 2028 (%)
14. GLOBAL WOMEN HEALTH DIAGNOSTICS IN DIAGNOSTIC AND IMAGING CENTERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL WOMEN HEALTH DIAGNOSTICS IN HOSPITALS AND CLINICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. GLOBAL WOMEN HEALTH DIAGNOSTICS IN HOME CARE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17. GLOBAL WOMEN HEALTH DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
18. US WOMEN HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
19. CANADA WOMEN HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
20. UK WOMEN HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
21. FRANCE WOMEN HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
22. GERMANY WOMEN HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
23. ITALY WOMEN HEALTH DIAGNOSTICS MARKET, 2021-2028 ($ MILLION)
24. SPAIN WOMEN HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
25. ROE WOMEN HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
26. INDIA WOMEN HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
27. CHINA WOMEN HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
28. JAPAN WOMEN HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
29. REST OF ASIA-PACIFIC WOMEN HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
30. REST OF THE WORLD WOMEN HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
